A retrospective case series of eight patients with epidermal growth factor receptor inhibitor-induced cutaneous toxicities managed with dupilumab

JAAD Case Rep. 2024 Sep 16:54:17-22. doi: 10.1016/j.jdcr.2024.08.031. eCollection 2024 Dec.
No abstract available

Keywords: acneiform eruption; cancer care; cutaneous toxicity; dermatitis; dupilumab; eczematous dermatitis; epidermal growth factor inhibitor; erosive pustular dermatosis; oncodermatologist; oncodermatology; pruritus; targeted therapy; toxicity.

Publication types

  • Case Reports